Skip to content

MEO NextGenDeveloper StudioDEV

Additional Insight · Snapshot · Review / Edit

Antepartum haemorrhage – RhD-negative women require a haemorrhage-specific prophylaxis assessment

Record #24 · Edit the content, source and classification relationships.

SQL status stored

Candidate visibility Not candidate-visible

Type Snapshot

Related questions 9

Additional Insights list

Additional Insight #24

Type

Status

Currently stored: stored

Status control does not offer the stored value. This record is stored as stored, but this legacy control only offers generated / needs_review / approved / retired. Saving will submit the selected value (currently generated) and replace stored.

This is a known backend issue reported separately; it has not been changed in this visual redesign.

Title

Content

Source

Source

Section

Locator

Notes

UUID — protected

b53afa4d-3fab-4e0f-9169-7aaf13f56be5

Classification Relationships — through Subtopic3

3 assigned

Obstetrics and Gynaecology→ Clinical→ Delivery suite→ Haemorrhage→ Antepartum haemorrhage→ General→ Fetomaternal haemorrhage testing

Obstetrics and Gynaecology→ Clinical→ Delivery suite→ Haemorrhage→ Antepartum haemorrhage→ General→ RhD-negative anti-D prophylaxis

Obstetrics and Gynaecology→ Clinical→ Delivery suite→ Haemorrhage→ Antepartum haemorrhage→ General→ Rhesus prophylaxis

Related Questions (9)

Matched through Subtopic3

SSBAQ65 generated

An RhD-negative woman at 31 weeks presents with a significant antepartum haemorrhage. She has no anti-D antibodies. Which investigation is specifically required to determine whether additional anti-D immunoglobulin is necessary?

Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis

SSBAQ76 generated

A non-sensitised RhD-negative woman at 30 weeks has recurrent episodes of antepartum haemorrhage. She received anti-D immunoglobulin following an earlier episode three weeks ago. She now presents with another significant bleed. Which statement is most appropriate?

Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis

SSBAQ136 generated

An unsensitised RhD-negative woman at 34 weeks has a significant APH. A standard dose of anti-D immunoglobulin is given. Kleihauer testing subsequently demonstrates a fetomaternal haemorrhage exceeding that covered by the administered dose. What is the most appropriate next step?

Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis

SSBAQ166 generated

An unsensitised RhD-negative woman has recurrent APH at 29, 31 and 33 weeks. She received anti-D after the first episode. Following the third episode, a colleague argues that no further prophylactic assessment is necessary because all three bleeds probably arise from the same placental pathology. Which principle is most appropriate?

Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis

SSBAQ170 generated

An unsensitised RhD-negative woman at 33 weeks presents with painful APH and uterine tenderness. Ultrasound demonstrates no retroplacental collection. Kleihauer testing shows a significant fetomaternal haemorrhage. Which interpretation is most accurate?

Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis

EEMQQ218 generated

Select the single most appropriate approach to rhesus prophylaxis.

Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis

EEMQQ230 generated

Select the single most appropriate investigation to determine whether additional anti-D immunoglobulin is required.

Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis

EEMQQ261 generated

Select the single most appropriate rhesus-management principle.

Delivery suite → Haemorrhage → Antepartum haemorrhage → General → RhD-negative anti-D prophylaxis

EEMQQ262 generated

Select the single most appropriate purpose of fetomaternal haemorrhage testing in this setting.

Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Fetomaternal haemorrhage testing